{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:13:12Z","timestamp":1778825592743,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["30-37"],"award-info":[{"award-number":["30-37"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jogc.2023.102255","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:01:36Z","timestamp":1698667296000},"page":"102255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relationship Between Metabolic Syndrome and Polycystic Ovary Syndrome with Special Reference to C-Reactive Protein"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8905-4870","authenticated-orcid":false,"given":"Eman M.","family":"Alissa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samiah A.","family":"Algarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza J.","family":"Khaffji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisma M.","family":"Al Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2023.102255_bib1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.jogc.2023.102255_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jogc.2023.102255_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jogc.2023.102255_bib4","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jogc.2023.102255_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2023.102255_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000341838","article-title":"Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome","volume":"40","author":"Bajuk Studen","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.jogc.2023.102255_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/14728222.2015.1101067","article-title":"Targets to treat metabolic syndrome in polycystic ovary syndrome","volume":"19","author":"Mahalingaiah","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jogc.2023.102255_bib8","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2023.102255_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2023.102255_bib10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/sj.ijo.0801723","article-title":"Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians","volume":"25","author":"Forouhi","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.jogc.2023.102255_bib11","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000041046.32962.86","article-title":"Differentiation between obesity and insulin resistance in the association with C-reactive protein","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jogc.2023.102255_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.102255_bib13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2023.102255_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jogc.2023.102255_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.102255_bib16","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?","volume":"102","author":"Daan","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.102255_bib17","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2023.102255_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.102255_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","article-title":"Is PCOS an inflammatory process?","volume":"97","author":"Duleba","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.102255_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1210\/jc.2006-0513","article-title":"Metabolic syndrome: a multiplex cardiovascular risk factor","volume":"92","author":"Grundy","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2023.102255_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/met.2007.0034","article-title":"Association of adiposity, inflammation and atherosclerosis: the role of adipocytokines and CRP in Asian Indian subjects","volume":"6","author":"Mahadik","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jogc.2023.102255_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3132\/dvdr.2005.004","article-title":"Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects","volume":"2","author":"Chu","year":"2005","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jogc.2023.102255_bib23","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/humrep\/der096","article-title":"No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls","volume":"26","author":"Lindholm","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2023.102255_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0895-4356(96)00367-8","article-title":"Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: a nested case-referent study in the DOM-cohort","volume":"50","author":"Gorgels","year":"1997","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jogc.2023.102255_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2265.2001.01228.x","article-title":"Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters","volume":"54","author":"Pirwany","year":"2001","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216323006163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216323006163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:50:19Z","timestamp":1778824219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216323006163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1701216323006163"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2023.102255","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship Between Metabolic Syndrome and Polycystic Ovary Syndrome with Special Reference to C-Reactive Protein","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2023.102255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102255"}}